Xiangyu Medical Co.,Ltd
- Jurisdiction
South Korea - ISIN
CNE100005394 (688626.SS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Xiangyu Medical Co.,Ltd engages in the research, development, production, marketing, and sale of rehabilitation, physiotherapy, and pain management equipment to multinational organizations and small individual companies. Read full profile
Fundamentals
- Net revenue
€90.99M - Gross margin
67.3% - EBIT
€10.42M - EBIT margin
11.4% - Net income
€9.72M - Net margin
10.7%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
CN¥0.24 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
51.5%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions